AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results.

Check out this month's People Pathways newsletter where you can read about: 

Experience the ‘Agile’ way of thinking in this practical taster session and find out how Agile project management can boost efficiency, help reduce costs and promote continuous improvement. The session is planned for Thursday July 6 at St John's Innovation Centre, Cambridge.

Qualified Scrum Master and Scrum Coach from Hethel Innovation, Sam Payne, will lead you through the basic principles of ‘Agile’ project management to give you an insight into the Agile approach to achieving your business goals.

Attracting and retaining talent in STEM is business critical.

According to almost three-quarters of global senior leaders, talent and skills shortages are the greatest barrier to business strategy over the next 12 months.

In this competitive and skills-short market, understanding current salary levels can unlock better recruitment outcomes faster to help you retain, and attract the most skilled talent.

Kadans Science Partner will add Windrush Innovation Centre in Oxford, UK to its Pan-European portfolio. The asset will be freehold acquired from Tozi Limited. Kadans intends to demolish the existing building and create over 60,000 sq ft of new high specification laboratory and office space in partnership with the tenant, Oxford Biomedica.

PharmEnable Closes $7.5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases

YouGov, on behalf of Bidwells, are carrying out a survey of the Tech sector.

The purpose of the study is to help the real estate sector and policy makers understand the requirements and preferences of organisations so they might better provide property and infrastructure for your industry in the future.

The survey looks at the location and property requirements of the tech sector overall. There are also some additional questions for companies, currently or potentially, working in the areas of health and life sciences.

Click here to view the May 2023 edition of The Meeting Place.

The University of Birmingham’s Clinical Immunology Service (CIS) is soon to become the anchor tenant at the forthcoming Precision Health Technology Accelerator (PHTA), after signing up to occupy ~10,000 sq ft of the custom-built flagship research facility.

Providing a comprehensive range of accredited lab services to facilitate the diagnosis of autoimmune and neuroimmunological disease, blood cancers, primary and secondary immunodeficiency, infections and allergy, the CIS receives more than 100,000 blood, marrow, urine and other samples per year.

Early-stage life sciences enterprises are set to benefit from a unique new collaboration between Birmingham’s Precision Health Technologies Accelerator (PHTA) and Oxford Science Enterprises (OSE).

The partnership will focus on helping high-growth health technology and life sciences companies to scale, primarily through access to high-quality lab and innovation space, while also catalysing cross-regional collaboration between academics and enterprises.